The global Recombinant Plasma Protein Therapeutics market was valued at US$ 92 million in 2023 and is anticipated to reach US$ 136.1 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.

Recombinant Plasma Protein Therapeutics Market

Recombinant plasma protein therapeutics market is driven by various factors such as shift from use of plasma-derived proteins to recombinant therapies, rise in awareness about rare disease management and increased focus on investments in rare diseases.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Recombinant Plasma Protein Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Plasma Protein Therapeutics.

Report Scope

The Recombinant Plasma Protein Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Plasma Protein Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Plasma Protein Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Recombinant Plasma Protein Therapeutics Market Report

Report Metric	Details
Report Name	Recombinant Plasma Protein Therapeutics Market
Accounted market size in 2023	US$ 92 million
Forecasted market size in 2030	US$ 136.1 million
CAGR	5.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Recombinant Coagulation Factors Human C1 Esterase Inhibitor
Segment by Application	Hemophilia A Hemophilia B Von Willebrand Disease
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CSL Limited, Takeda, Octapharma, Novo Nordisk A/S, Pfizer, Bioverativ Therapeutics, Aptevo Therapeutics, Pharming Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Plasma Protein Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Plasma Protein Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Recombinant Plasma Protein Therapeutics Market growing?

Ans: The Recombinant Plasma Protein Therapeutics Market witnessing a CAGR of 5.8% during the forecast period 2024-2030.

What is the Recombinant Plasma Protein Therapeutics Market size in 2030?

Ans: The Recombinant Plasma Protein Therapeutics Market size in 2030 will be US$ 136.1 million.

Who are the main players in the Recombinant Plasma Protein Therapeutics Market report?

Ans: The main players in the Recombinant Plasma Protein Therapeutics Market are CSL Limited, Takeda, Octapharma, Novo Nordisk A/S, Pfizer, Bioverativ Therapeutics, Aptevo Therapeutics, Pharming Group

What are the Application segmentation covered in the Recombinant Plasma Protein Therapeutics Market report?

Ans: The Applications covered in the Recombinant Plasma Protein Therapeutics Market report are Hemophilia A, Hemophilia B, Von Willebrand Disease

What are the Type segmentation covered in the Recombinant Plasma Protein Therapeutics Market report?

Ans: The Types covered in the Recombinant Plasma Protein Therapeutics Market report are Recombinant Coagulation Factors, Human C1 Esterase Inhibitor

1 Recombinant Plasma Protein Therapeutics Market Overview

1.1 Product Overview and Scope of Recombinant Plasma Protein Therapeutics

1.2 Recombinant Plasma Protein Therapeutics Segment by Type

1.2.1 Global Recombinant Plasma Protein Therapeutics Market Value Comparison by Type (2024-2030)

1.2.2 Recombinant Coagulation Factors

1.2.3 Human C1 Esterase Inhibitor

1.3 Recombinant Plasma Protein Therapeutics Segment by Application

1.3.1 Global Recombinant Plasma Protein Therapeutics Market Value by Application: (2024-2030)

1.3.2 Hemophilia A

1.3.3 Hemophilia B

1.3.4 Von Willebrand Disease

1.4 Global Recombinant Plasma Protein Therapeutics Market Size Estimates and Forecasts

1.4.1 Global Recombinant Plasma Protein Therapeutics Revenue 2019-2030

1.4.2 Global Recombinant Plasma Protein Therapeutics Sales 2019-2030

1.4.3 Global Recombinant Plasma Protein Therapeutics Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Recombinant Plasma Protein Therapeutics Market Competition by Manufacturers

2.1 Global Recombinant Plasma Protein Therapeutics Sales Market Share by Manufacturers (2019-2024)

2.2 Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Recombinant Plasma Protein Therapeutics Average Price by Manufacturers (2019-2024)

2.4 Global Recombinant Plasma Protein Therapeutics Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Recombinant Plasma Protein Therapeutics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Recombinant Plasma Protein Therapeutics, Product Type & Application

2.7 Recombinant Plasma Protein Therapeutics Market Competitive Situation and Trends

2.7.1 Recombinant Plasma Protein Therapeutics Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Recombinant Plasma Protein Therapeutics Players Market Share by Revenue

2.7.3 Global Recombinant Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Recombinant Plasma Protein Therapeutics Retrospective Market Scenario by Region

3.1 Global Recombinant Plasma Protein Therapeutics Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Recombinant Plasma Protein Therapeutics Global Recombinant Plasma Protein Therapeutics Sales by Region: 2019-2030

3.2.1 Global Recombinant Plasma Protein Therapeutics Sales by Region: 2019-2024

3.2.2 Global Recombinant Plasma Protein Therapeutics Sales by Region: 2025-2030

3.3 Global Recombinant Plasma Protein Therapeutics Global Recombinant Plasma Protein Therapeutics Revenue by Region: 2019-2030

3.3.1 Global Recombinant Plasma Protein Therapeutics Revenue by Region: 2019-2024

3.3.2 Global Recombinant Plasma Protein Therapeutics Revenue by Region: 2025-2030

3.4 North America Recombinant Plasma Protein Therapeutics Market Facts & Figures by Country

3.4.1 North America Recombinant Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Recombinant Plasma Protein Therapeutics Sales by Country (2019-2030)

3.4.3 North America Recombinant Plasma Protein Therapeutics Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Recombinant Plasma Protein Therapeutics Market Facts & Figures by Country

3.5.1 Europe Recombinant Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Recombinant Plasma Protein Therapeutics Sales by Country (2019-2030)

3.5.3 Europe Recombinant Plasma Protein Therapeutics Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Recombinant Plasma Protein Therapeutics Market Facts & Figures by Country

3.6.1 Asia Pacific Recombinant Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Recombinant Plasma Protein Therapeutics Sales by Country (2019-2030)

3.6.3 Asia Pacific Recombinant Plasma Protein Therapeutics Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Recombinant Plasma Protein Therapeutics Market Facts & Figures by Country

3.7.1 Latin America Recombinant Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Recombinant Plasma Protein Therapeutics Sales by Country (2019-2030)

3.7.3 Latin America Recombinant Plasma Protein Therapeutics Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Recombinant Plasma Protein Therapeutics Market Facts & Figures by Country

3.8.1 Middle East and Africa Recombinant Plasma Protein Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Recombinant Plasma Protein Therapeutics Sales by Country (2019-2030)

3.8.3 Middle East and Africa Recombinant Plasma Protein Therapeutics Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Recombinant Plasma Protein Therapeutics Sales by Type (2019-2030)

4.1.1 Global Recombinant Plasma Protein Therapeutics Sales by Type (2019-2024)

4.1.2 Global Recombinant Plasma Protein Therapeutics Sales by Type (2025-2030)

4.1.3 Global Recombinant Plasma Protein Therapeutics Sales Market Share by Type (2019-2030)

4.2 Global Recombinant Plasma Protein Therapeutics Revenue by Type (2019-2030)

4.2.1 Global Recombinant Plasma Protein Therapeutics Revenue by Type (2019-2024)

4.2.2 Global Recombinant Plasma Protein Therapeutics Revenue by Type (2025-2030)

4.2.3 Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Type (2019-2030)

4.3 Global Recombinant Plasma Protein Therapeutics Price by Type (2019-2030)

5 Segment by Application

5.1 Global Recombinant Plasma Protein Therapeutics Sales by Application (2019-2030)

5.1.1 Global Recombinant Plasma Protein Therapeutics Sales by Application (2019-2024)

5.1.2 Global Recombinant Plasma Protein Therapeutics Sales by Application (2025-2030)

5.1.3 Global Recombinant Plasma Protein Therapeutics Sales Market Share by Application (2019-2030)

5.2 Global Recombinant Plasma Protein Therapeutics Revenue by Application (2019-2030)

5.2.1 Global Recombinant Plasma Protein Therapeutics Revenue by Application (2019-2024)

5.2.2 Global Recombinant Plasma Protein Therapeutics Revenue by Application (2025-2030)

5.2.3 Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Application (2019-2030)

5.3 Global Recombinant Plasma Protein Therapeutics Price by Application (2019-2030)

6 Key Companies Profiled

6.1 CSL Limited

6.1.1 CSL Limited Corporation Information

6.1.2 CSL Limited Description and Business Overview

6.1.3 CSL Limited Recombinant Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

6.1.4 CSL Limited Recombinant Plasma Protein Therapeutics Product Portfolio

6.1.5 CSL Limited Recent Developments/Updates

6.2 Takeda

6.2.1 Takeda Corporation Information

6.2.2 Takeda Description and Business Overview

6.2.3 Takeda Recombinant Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Takeda Recombinant Plasma Protein Therapeutics Product Portfolio

6.2.5 Takeda Recent Developments/Updates

6.3 Octapharma

6.3.1 Octapharma Corporation Information

6.3.2 Octapharma Description and Business Overview

6.3.3 Octapharma Recombinant Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Octapharma Recombinant Plasma Protein Therapeutics Product Portfolio

6.3.5 Octapharma Recent Developments/Updates

6.4 Novo Nordisk A/S

6.4.1 Novo Nordisk A/S Corporation Information

6.4.2 Novo Nordisk A/S Description and Business Overview

6.4.3 Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Product Portfolio

6.4.5 Novo Nordisk A/S Recent Developments/Updates

6.5 Pfizer

6.5.1 Pfizer Corporation Information

6.5.2 Pfizer Description and Business Overview

6.5.3 Pfizer Recombinant Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Pfizer Recombinant Plasma Protein Therapeutics Product Portfolio

6.5.5 Pfizer Recent Developments/Updates

6.6 Bioverativ Therapeutics

6.6.1 Bioverativ Therapeutics Corporation Information

6.6.2 Bioverativ Therapeutics Description and Business Overview

6.6.3 Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Product Portfolio

6.6.5 Bioverativ Therapeutics Recent Developments/Updates

6.7 Aptevo Therapeutics

6.6.1 Aptevo Therapeutics Corporation Information

6.6.2 Aptevo Therapeutics Description and Business Overview

6.6.3 Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Product Portfolio

6.7.5 Aptevo Therapeutics Recent Developments/Updates

6.8 Pharming Group

6.8.1 Pharming Group Corporation Information

6.8.2 Pharming Group Description and Business Overview

6.8.3 Pharming Group Recombinant Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Pharming Group Recombinant Plasma Protein Therapeutics Product Portfolio

6.8.5 Pharming Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Recombinant Plasma Protein Therapeutics Industry Chain Analysis

7.2 Recombinant Plasma Protein Therapeutics Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Recombinant Plasma Protein Therapeutics Production Mode & Process

7.4 Recombinant Plasma Protein Therapeutics Sales and Marketing

7.4.1 Recombinant Plasma Protein Therapeutics Sales Channels

7.4.2 Recombinant Plasma Protein Therapeutics Distributors

7.5 Recombinant Plasma Protein Therapeutics Customers

8 Recombinant Plasma Protein Therapeutics Market Dynamics

8.1 Recombinant Plasma Protein Therapeutics Industry Trends

8.2 Recombinant Plasma Protein Therapeutics Market Drivers

8.3 Recombinant Plasma Protein Therapeutics Market Challenges

8.4 Recombinant Plasma Protein Therapeutics Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bioverativ Therapeutics

Aptevo Therapeutics

Pharming Group

List of Tables

Table 1. Global Recombinant Plasma Protein Therapeutics Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Recombinant Plasma Protein Therapeutics Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Recombinant Plasma Protein Therapeutics Market Competitive Situation by Manufacturers in 2023

Table 4. Global Recombinant Plasma Protein Therapeutics Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Recombinant Plasma Protein Therapeutics Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Recombinant Plasma Protein Therapeutics Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Recombinant Plasma Protein Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Recombinant Plasma Protein Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Recombinant Plasma Protein Therapeutics, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Recombinant Plasma Protein Therapeutics, Product Type & Application

Table 12. Global Key Manufacturers of Recombinant Plasma Protein Therapeutics, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Recombinant Plasma Protein Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Plasma Protein Therapeutics as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Recombinant Plasma Protein Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Recombinant Plasma Protein Therapeutics Sales by Region (2019-2024) & (K Units)

Table 18. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Region (2019-2024)

Table 19. Global Recombinant Plasma Protein Therapeutics Sales by Region (2025-2030) & (K Units)

Table 20. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Region (2025-2030)

Table 21. Global Recombinant Plasma Protein Therapeutics Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Region (2019-2024)

Table 23. Global Recombinant Plasma Protein Therapeutics Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Region (2025-2030)

Table 25. North America Recombinant Plasma Protein Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Recombinant Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)

Table 27. North America Recombinant Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)

Table 28. North America Recombinant Plasma Protein Therapeutics Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Recombinant Plasma Protein Therapeutics Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Recombinant Plasma Protein Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Recombinant Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)

Table 32. Europe Recombinant Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)

Table 33. Europe Recombinant Plasma Protein Therapeutics Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Recombinant Plasma Protein Therapeutics Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Recombinant Plasma Protein Therapeutics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Recombinant Plasma Protein Therapeutics Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Recombinant Plasma Protein Therapeutics Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Recombinant Plasma Protein Therapeutics Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Recombinant Plasma Protein Therapeutics Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Recombinant Plasma Protein Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Recombinant Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Recombinant Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Recombinant Plasma Protein Therapeutics Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Recombinant Plasma Protein Therapeutics Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Recombinant Plasma Protein Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Recombinant Plasma Protein Therapeutics Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Recombinant Plasma Protein Therapeutics Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Recombinant Plasma Protein Therapeutics Sales (K Units) by Type (2019-2024)

Table 51. Global Recombinant Plasma Protein Therapeutics Sales (K Units) by Type (2025-2030)

Table 52. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)

Table 53. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Type (2025-2030)

Table 54. Global Recombinant Plasma Protein Therapeutics Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Recombinant Plasma Protein Therapeutics Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Type (2019-2024)

Table 57. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Type (2025-2030)

Table 58. Global Recombinant Plasma Protein Therapeutics Price (USD/Unit) by Type (2019-2024)

Table 59. Global Recombinant Plasma Protein Therapeutics Price (USD/Unit) by Type (2025-2030)

Table 60. Global Recombinant Plasma Protein Therapeutics Sales (K Units) by Application (2019-2024)

Table 61. Global Recombinant Plasma Protein Therapeutics Sales (K Units) by Application (2025-2030)

Table 62. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)

Table 63. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Application (2025-2030)

Table 64. Global Recombinant Plasma Protein Therapeutics Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Recombinant Plasma Protein Therapeutics Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Application (2019-2024)

Table 67. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Application (2025-2030)

Table 68. Global Recombinant Plasma Protein Therapeutics Price (USD/Unit) by Application (2019-2024)

Table 69. Global Recombinant Plasma Protein Therapeutics Price (USD/Unit) by Application (2025-2030)

Table 70. CSL Limited Corporation Information

Table 71. CSL Limited Description and Business Overview

Table 72. CSL Limited Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. CSL Limited Recombinant Plasma Protein Therapeutics Product

Table 74. CSL Limited Recent Developments/Updates

Table 75. Takeda Corporation Information

Table 76. Takeda Description and Business Overview

Table 77. Takeda Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Takeda Recombinant Plasma Protein Therapeutics Product

Table 79. Takeda Recent Developments/Updates

Table 80. Octapharma Corporation Information

Table 81. Octapharma Description and Business Overview

Table 82. Octapharma Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Octapharma Recombinant Plasma Protein Therapeutics Product

Table 84. Octapharma Recent Developments/Updates

Table 85. Novo Nordisk A/S Corporation Information

Table 86. Novo Nordisk A/S Description and Business Overview

Table 87. Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Product

Table 89. Novo Nordisk A/S Recent Developments/Updates

Table 90. Pfizer Corporation Information

Table 91. Pfizer Description and Business Overview

Table 92. Pfizer Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Pfizer Recombinant Plasma Protein Therapeutics Product

Table 94. Pfizer Recent Developments/Updates

Table 95. Bioverativ Therapeutics Corporation Information

Table 96. Bioverativ Therapeutics Description and Business Overview

Table 97. Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Product

Table 99. Bioverativ Therapeutics Recent Developments/Updates

Table 100. Aptevo Therapeutics Corporation Information

Table 101. Aptevo Therapeutics Description and Business Overview

Table 102. Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Product

Table 104. Aptevo Therapeutics Recent Developments/Updates

Table 105. Pharming Group Corporation Information

Table 106. Pharming Group Description and Business Overview

Table 107. Pharming Group Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Pharming Group Recombinant Plasma Protein Therapeutics Product

Table 109. Pharming Group Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Recombinant Plasma Protein Therapeutics Distributors List

Table 113. Recombinant Plasma Protein Therapeutics Customers List

Table 114. Recombinant Plasma Protein Therapeutics Market Trends

Table 115. Recombinant Plasma Protein Therapeutics Market Drivers

Table 116. Recombinant Plasma Protein Therapeutics Market Challenges

Table 117. Recombinant Plasma Protein Therapeutics Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Recombinant Plasma Protein Therapeutics

Figure 2. Global Recombinant Plasma Protein Therapeutics Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Recombinant Plasma Protein Therapeutics Market Share by Type in 2023 & 2030

Figure 4. Recombinant Coagulation Factors Product Picture

Figure 5. Human C1 Esterase Inhibitor Product Picture

Figure 6. Global Recombinant Plasma Protein Therapeutics Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Recombinant Plasma Protein Therapeutics Market Share by Application in 2023 & 2030

Figure 8. Hemophilia A

Figure 9. Hemophilia B

Figure 10. Von Willebrand Disease

Figure 11. Global Recombinant Plasma Protein Therapeutics Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Recombinant Plasma Protein Therapeutics Market Size (2019-2030) & (US$ Million)

Figure 13. Global Recombinant Plasma Protein Therapeutics Sales (2019-2030) & (K Units)

Figure 14. Global Recombinant Plasma Protein Therapeutics Average Price (USD/Unit) & (2019-2030)

Figure 15. Recombinant Plasma Protein Therapeutics Report Years Considered

Figure 16. Recombinant Plasma Protein Therapeutics Sales Share by Manufacturers in 2023

Figure 17. Global Recombinant Plasma Protein Therapeutics Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Recombinant Plasma Protein Therapeutics Players: Market Share by Revenue in 2023

Figure 19. Recombinant Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Recombinant Plasma Protein Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Recombinant Plasma Protein Therapeutics Sales Market Share by Country (2019-2030)

Figure 22. North America Recombinant Plasma Protein Therapeutics Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Recombinant Plasma Protein Therapeutics Sales Market Share by Country (2019-2030)

Figure 26. Europe Recombinant Plasma Protein Therapeutics Revenue Market Share by Country (2019-2030)

Figure 27. Germany Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Recombinant Plasma Protein Therapeutics Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Recombinant Plasma Protein Therapeutics Revenue Market Share by Region (2019-2030)

Figure 34. China Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Taiwan Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Philippines Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Recombinant Plasma Protein Therapeutics Sales Market Share by Country (2019-2030)

Figure 45. Latin America Recombinant Plasma Protein Therapeutics Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Recombinant Plasma Protein Therapeutics Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. U.A.E Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Recombinant Plasma Protein Therapeutics by Type (2019-2030)

Figure 55. Global Revenue Market Share of Recombinant Plasma Protein Therapeutics by Type (2019-2030)

Figure 56. Global Recombinant Plasma Protein Therapeutics Price (USD/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Recombinant Plasma Protein Therapeutics by Application (2019-2030)

Figure 58. Global Revenue Market Share of Recombinant Plasma Protein Therapeutics by Application (2019-2030)

Figure 59. Global Recombinant Plasma Protein Therapeutics Price (USD/Unit) by Application (2019-2030)

Figure 60. Recombinant Plasma Protein Therapeutics Value Chain

Figure 61. Recombinant Plasma Protein Therapeutics Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-12J14669

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical and Consumer Products Coding Equipment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-32H12616

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Co-Packing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-13K12891

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Nucleic Acid-based Drugs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-27P12567

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Recombinant Plasma Protein Therapeutics Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-38G7155

Global Recombinant Plasma Protein Therapeutics Market Research Report 2024

FEATURED COMPANIES

Recombinant Plasma Protein Therapeutics Market Size

Recombinant Plasma Protein Therapeutics Market

Report Scope

Scope of Recombinant Plasma Protein Therapeutics Market Report

Chapter Outline

FAQ for this report

How fast is Recombinant Plasma Protein Therapeutics Market growing?

What is the Recombinant Plasma Protein Therapeutics Market size in 2030?

Who are the main players in the Recombinant Plasma Protein Therapeutics Market report?

What are the Application segmentation covered in the Recombinant Plasma Protein Therapeutics Market report?

What are the Type segmentation covered in the Recombinant Plasma Protein Therapeutics Market report?

FEATURED COMPANIES

RELATED REPORTS